* GE launches USD$100 million open innovation challenge globally to find and fund ideas to accelerate detection of breast cancer and enable more personalized treatment
* GE supports improved care delivery to 10 million patients around the world by 2020
* Previews revolutionary mobile mammography technology to enable access to screenings for women in rural and underserved areas
* GE to invest USD$1billion on cancer R&D over five years
business unit
tags
Partners with INTER RAO UES and UEC in Energy, with RUSSIAN TECHNOLOGIES in Healthcare
GE expands presence in fast-growing Russian healthcare and energy markets
Anticipates orders of gas-fired power turbines with total capacity of up to 5 gigawatts of power as well as thousands of high-tech medical diagnostic units in Russia
business unit
NORWALK, CT-- September 16, 2011 --- GE Capital, Corporate Finance today announced it is co-syndication agent on a $600 million cash flow-based revolving credit facility for MasTec, Inc. (NYSE:MTZ), a leading infrastructure construction company. The financing will be used for growth and general corporate purposes. GE Capital Markets served as joint lead arranger and book manager.
business unit
tags
$100 million open innovation challenge to find and fund ideas to accelerate detection of breast cancer and enable more personalised treatment
New mobile mammography concept SenoCase™ to transform access to screening in underserved areas
SenoBright™, an exclusive imaging technique, improves accuracy of breast exams and helps doctors better identify patients who need biopsies
GE to invest $1 billion on cancer R&D over five years
Formation of cancer coalition in Australia to expand access to mammography screening and breast cancer technology